Hennion & Walsh Asset Management’s Chemed CHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$716K Sell
1,537
-170
-10% -$71.5K 0.02% 659
2026
Q1
$645K Sell
1,707
-27
-2% -$11.6K 0.02% 634
2025
Q4
$742K Sell
1,734
-46
-3% -$20K 0.03% 594
2025
Q3
$797K Sell
1,780
-1
-0.1% -$453 0.03% 569
2025
Q2
$867K Buy
1,781
+295
+20% +$168K 0.04% 525
2025
Q1
$914K Buy
1,486
+646
+77% +$367K 0.04% 491
2024
Q4
$445K Buy
840
+353
+72% +$199K 0.02% 655
2024
Q3
$293K Buy
+487
New +$276K 0.01% 741
2024
Q1
– Sell
-449
Closed -$263K – 851
2023
Q4
$263K Sell
449
-115
-20% -$64.4K 0.02% 712
2023
Q3
$293K Sell
564
-25
-4% -$13K 0.02% 652
2023
Q2
$319K Sell
589
-23
-4% -$12.6K 0.02% 637
2023
Q1
$329K Sell
612
-23
-4% -$11.7K 0.02% 616
2022
Q4
$324K Sell
635
-8
-1% -$3.89K 0.02% 601
2022
Q3
$281K Buy
643
+10
+2% +$4.81K 0.02% 633
2022
Q2
$297K Buy
633
+182
+40% +$88.8K 0.02% 631
2022
Q1
$228K Buy
+451
New +$216K 0.01% 712

Other funds holding CHE

Hennion & Walsh Asset Management's CHE Position: Q2 2026 in Review

Hennion & Walsh Asset Management reduced its Chemed (CHE) stake by 10% in Q2 2026, selling an estimated $71.5K and leaving 1,537 shares worth $716K. The position accounts for 0.02% of the portfolio, ranked #659.

Hennion & Walsh Asset Management first reported a position in CHE in Q1 2022 and has held it in 16 quarters since. The position peaked at $914K in Q1 2025. 532 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

  • Hennion & Walsh Asset Management held 1,537 shares of Chemed worth $716K as of Q2 2026.
  • Hennion & Walsh Asset Management sold 170 Chemed shares in Q2 2026, an estimated $71.5K.
  • Chemed made up 0.02% of Hennion & Walsh Asset Management's portfolio in Q2 2026, its #659 holding.
  • Hennion & Walsh Asset Management first reported a position in Chemed in Q1 2022 and has held it in 16 quarters since.
  • Hennion & Walsh Asset Management's Chemed position peaked at $914K in Q1 2025.
  • 532 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on Hennion & Walsh Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.